drugset / Trial / NCT04354805
Administration of Chlorpromazine as a Treatment for COVID-19
RandomizedParallel-groupSingle-blindTreatment
Summary
In this study, defined cases of COVID-19 confirmed with PCR, with a mild, moderate or severe pneumonia will be treated with chlorpromazine. The improvement in clinical \& laboratory manifestations will be evaluated in treated patient compared to control group.
Timeline
- Start
- 2020-08-01
- Primary completion
- 2020-10
- Completion
- 2020-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chlorpromazine | Small molecule | 100 mg | Oral |